Search research articles
Contact Us
Filters
Showing results (191-200 of 204) with videos related to
Page
of 21
Sort By:
The Journal of Infectious Diseases
|
December 17, 2024
Imipenem pharmacokinetics/pharmacodynamics in preclinical hollow fiber model, dose-finding in virtual patients, and clinical evidence of efficacy for Mycobacterium abscessus lung disease
Sanjay Singh, Tawanda Gumbo, Jann-Yuan Wang, et al.
Nature Medicine
|
March 9, 2023
Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial
Aliasgar Esmail, Philippa Randall, Suzette Oelofse, et al.
Nature Medicine
|
July 1, 2020
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
Grant Theron, Jason Limberis, Rouxjeane Venter, et al.
Frontiers in Microbiology
|
August 28, 2020
sncRNA-1 Is a Small Noncoding RNA Produced by <i>Mycobacterium tuberculosis</i> in Infected Cells That Positively Regulates Genes Coupled to Oleic Acid Biosynthesis
Fatma S Coskun, Shashikant Srivastava, Prithvi Raj, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2019
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models
Mike M Ruth, Gesham Magombedze, Tawanda Gumbo, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 21, 2019
A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin
Malika Davids, Anil Pooran, Clemens Hermann, et al.
The Journal of Antimicrobial Chemotherapy
|
June 9, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 8, 2018
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis
Keertan Dheda, Laura Lenders, Gesham Magombedze, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 30, 2019
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing
Keertan Dheda, Laura Lenders, Shashikant Srivastava, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal
Devyani Deshpande, Jan-Willem C Alffenaar, Claudio U Köser, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 204) with videos related to
Sort By:
Page
of 21
The Journal of Infectious Diseases
|
December 17, 2024
Imipenem pharmacokinetics/pharmacodynamics in preclinical hollow fiber model, dose-finding in virtual patients, and clinical evidence of efficacy for Mycobacterium abscessus lung disease
Sanjay Singh, Tawanda Gumbo, Jann-Yuan Wang, et al.
Nature Medicine
|
March 9, 2023
Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial
Aliasgar Esmail, Philippa Randall, Suzette Oelofse, et al.
Nature Medicine
|
July 1, 2020
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
Grant Theron, Jason Limberis, Rouxjeane Venter, et al.
Frontiers in Microbiology
|
August 28, 2020
sncRNA-1 Is a Small Noncoding RNA Produced by <i>Mycobacterium tuberculosis</i> in Infected Cells That Positively Regulates Genes Coupled to Oleic Acid Biosynthesis
Fatma S Coskun, Shashikant Srivastava, Prithvi Raj, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 2019
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models
Mike M Ruth, Gesham Magombedze, Tawanda Gumbo, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 21, 2019
A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin
Malika Davids, Anil Pooran, Clemens Hermann, et al.
The Journal of Antimicrobial Chemotherapy
|
June 9, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 8, 2018
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis
Keertan Dheda, Laura Lenders, Gesham Magombedze, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 30, 2019
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing
Keertan Dheda, Laura Lenders, Shashikant Srivastava, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal
Devyani Deshpande, Jan-Willem C Alffenaar, Claudio U Köser, et al.
Page
of 21